Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myo-inositol + folic acid
- Development stage
- Phase 1
- Lead developer
- BioSyent
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
myo-inositol + folic acid is a combination therapeutic and dietary supplement primarily indicated for the management of Polycystic Ovary Syndrome (PCOS). Myo-inositol, a carbocyclic sugar, serves as a second messenger for insulin and follicle-stimulating hormone (FSH), helping to improve insulin sensitivity, reduce hyperandrogenism, and restore regular ovulatory cycles. Folic acid (vitamin B9) is included to support DNA synthesis and cellular division, particularly to reduce the risk of neural tube defects in women of childbearing age. The combination is marketed under various brand names, including Inofolic, and is also being investigated for the treatment of ano-perineal fistulas and the management of metabolic markers like asprosin during pregnancy.
- Brand names
- InofolicMiocystinnbCalm
- Other names
- myo-inositol and folic acidinositol and folic acid
02
Targets
FSHR (Follicle-stimulating hormone receptor)INSR (Insulin receptor)DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on myo-inositol + folic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myo-inositol + folic acid.